Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,639 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic sarcoidosis with an increased serum level of immunoglobulin G4.
Inoue M, Chiba T, Zen Y, Yokota H, Kanda T, Ogasawara S, Sugiyama H, Arai M, Kanai F, Ogawa M, Imazeki F, Yokosuka O. Inoue M, et al. Intern Med. 2012;51(21):3095-8. doi: 10.2169/internalmedicine.51.8224. Epub 2012 Nov 1. Intern Med. 2012. PMID: 23124158 Free article.
Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia.
Takahashi K, Suzuki E, Yokoyama M, Inoue M, Wakamatsu T, Saito T, Kusakabe Y, Ogasawara S, Ooka Y, Tawada A, Nagao Y, Nakaseko C, Chiba T. Takahashi K, et al. Among authors: inoue m. Case Rep Gastroenterol. 2017 Jan 27;11(1):29-35. doi: 10.1159/000454710. eCollection 2017 Jan-Apr. Case Rep Gastroenterol. 2017. PMID: 28203135 Free PMC article.
Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
Yokoyama M, Chiba T, Zen Y, Oshima M, Kusakabe Y, Noguchi Y, Yuki K, Koide S, Tara S, Saraya A, Aoyama K, Mimura N, Miyagi S, Inoue M, Wakamatsu T, Saito T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Yokosuka O, Iwama A. Yokoyama M, et al. Among authors: inoue m. Oncotarget. 2017 Mar 28;8(13):21315-21326. doi: 10.18632/oncotarget.15528. Oncotarget. 2017. PMID: 28423509 Free PMC article.
Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment.
Ogasawara S, Chiba T, Ooka Y, Suzuki E, Maeda T, Yokoyama M, Wakamatsu T, Inoue M, Saito T, Kobayashi K, Kiyono S, Nakamura M, Nakamoto S, Yasui S, Tawada A, Arai M, Kanda T, Maruyama H, Yokosuka O, Kato N. Ogasawara S, et al. Among authors: inoue m. Invest New Drugs. 2018 Apr;36(2):332-339. doi: 10.1007/s10637-017-0507-3. Epub 2017 Sep 11. Invest New Drugs. 2018. PMID: 28891038
Henoch-Schönlein Purpura Complicated by Hepatocellular Carcinoma.
Akizue N, Suzuki E, Yokoyama M, Inoue M, Wakamatsu T, Saito T, Kusakabe Y, Ogasawara S, Ooka Y, Tawada A, Maru Y, Matsue H, Chiba T. Akizue N, et al. Among authors: inoue m. Intern Med. 2017 Nov 15;56(22):3041-3045. doi: 10.2169/internalmedicine.8885-17. Epub 2017 Sep 25. Intern Med. 2017. PMID: 28943572 Free PMC article.
8,639 results